NewAmsterdam Pharma (NAMS) Shares Outstanding (Entity) (2021 - 2026)

NewAmsterdam Pharma (NAMS) Shares Outstanding (Entity) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 253.35 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 139.80 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 62.54 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 214.24 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 113.02 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 575.47 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 133.73 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 218.28 Mn
10 NewAmsterdam Pharma 3.17 Bn 3.17 Bn - 117.65 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 57.92 Mn
Mar 31, 2026 57.14 Mn
Dec 31, 2025 55.60 Mn
Sep 30, 2025 55.87 Mn
Jun 30, 2025 55.66 Mn
Mar 31, 2025 54.52 Mn
Dec 31, 2024 44.30 Mn
Sep 30, 2024 44.49 Mn
Jun 30, 2024 44.47 Mn
Mar 31, 2024 41.49 Mn
Dec 31, 2023 38.57 Mn
Sep 30, 2023 38.72 Mn
Jun 30, 2023 38.53 Mn
Mar 31, 2023 38.33 Mn
Dec 31, 2022 38.29 Mn
Dec 31, 2021 11.33 Mn